Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain is a type of nerve pain that occurs in people with diabetes, often causing burning, tingling, or sharp pain in the feet and hands due to nerve damage.
Medical Cannabis Aerosol for Diabetic Peripheral Neuropathic Pain
We are studying whether a medical cannabis aerosol can help reduce pain for people with diabetic peripheral neuropathic pain. Participants will compare different doses of THC to a placebo to assess pain relief and quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have diabetes (type 1 or type 2)?
- Have you had daily foot pain for at least 3 months that is related to your diabetes?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications for pain like gabapentin, duloxetine, or pregabalin?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Cannabis Sativa
Cannabis
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
MP-neuro s.r.o.
Neurology
Ostrava, Czechia
Neuros s.r.o.
Neurology
Pilsen, Czechia
Clintrial s.r.o.
Prague, Czechia
Sponsor: Syqe Medical Ltd.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.